Latest EDGAR 4 filed on 2026-07-07, report date 2026-07-02: Kapusta Matthew C / uniQure N.V. reports ownership changes; on 07/02/2026; in Ordinary Shares; including 21,082 shares at 19.39 per share; 540,309 shares at 44.43 per share; 9,200 shares at 44.43 per share; 531,109 shares at 45.43 per share; 4,282 shares at 45.43 per share; 526,827 shares at 45.89 per share; 7,600 shares at 45.89 per share; 1. The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on October 5, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. 2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $44.10 to $44.80. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. 3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.00 to $45.95. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. 4. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.48 to $46.10. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. 5. The Stock Option vested in full on January 26, 2022. /s/ Christian Klemt, Attorney-in-Fact 07/07/2026 ** Signature of Reporting Person Date Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Stock detail
Uniqure (QURE) stock price, chart, and key data
View Uniqure stock price, chart movement, and headline metrics on Woodstock's stock detail page.

Stock detail
Uniqure
QURE · XNAS
-$3.59 (-9.17%) past day
$35.57
After hours $37.21 (-2.62%)
Key metrics
Earnings
Quarterly results and the next expected release
FY25 Q2
Q3
Q4
FY26 Q1
Q2
Q3
Day range
$35.44 - $39.90
52-week range
$8.73 - $71.50
Close price
$38.21
Market cap
$2.7B
P/E ratio
-56
Beta
0.9
About the company
UNIQURE BV
uniQure is a Dutch biopharmaceutical company which makes gene therapies. It has developed several adeno-associated virus gene therapies.
24/5 Trading
Act on the stock when the timing works for you.
With Woodstock, you can move from chart review to order placement in one flow. Trade eligible US stocks 24/5, even outside regular market hours.
*24-hour trading is available except during system maintenance. Some stocks are not eligible for extended-hours trading.
Download the app